---
category: news
title: "Endeavor BioMedicines Partners with xCures to Identify Patients with PTCH1 mutations for Phase 2 Trial of ENV-101 (taladegib)"
excerpt: "Cures to use tumor sequencing information and its platform to pair patients with available treatment optionsSAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines, a clinical-stage biotechnology company targeting the core drivers of terminal diseases including oncology and fibrosis,"
publishedDateTime: 2022-05-31T15:00:00Z
originalUrl: "https://us.acrofan.com/detail.php?number=672007"
webUrl: "https://us.acrofan.com/detail.php?number=672007"
type: article
quality: 0
heat: 0
published: false

provider:
  name: 아크로팬
  domain: acrofan.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://us.acrofan.com/news_images/2021/01/14/mark/20210114482917.jpg"
    width: 580
    height: 339
    isCached: true

secured: "RLwAhfXNO5eZAzmRJJXYBjvdsWzWm8a56afciKfvD/SkInw6UZICJe76DUfU86R0llsYFA6P3o/vFlxBD2bAWiYU/8qFYYgkNgZvLKnQA3Y+f2L8CMWcHRIpQF6q9yIC2LWiakR7rXJNYvh2p98on7OY0ID1gMr9woGZbtgxNoGSDF4vcv25RL7tt+CmFzGPEuKCwm9jPyJoNPiZIxyfb89/g1tgHQyqJ0aoy5eln+EWtGhFxu2fQxVpUPtu9SsbgQK+4m3nOaulThuNlMQkMt6q0e2lNETNAM3gQKHXGRiGYznBYIHkZS85puRIoU30OlsSpZSWp/0eM16fDlZzZO7cgVp9tRkvywgmZ+5AUzA=;y8XYH4gdYhpZnjt/fOexEg=="
---

